Menu Back toST00: Current Status of Clinical Development for Depression. -Issues, Lesson Learns, Solutions-

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

ST00: Current Status of Clinical Development for Depression. -Issues, Lesson Learns, Solutions-

Session Chair(s)

Marika  Uchida

Marika Uchida

  • Undergraduate
  • Meiji Pharmaceutical University, School of Pharmacy, Japan
Moeka  Yamanoi

Moeka Yamanoi

  • Undergraduate
  • Meiji Pharmaceutical University, School of Pharmacy, Japan
Yuni  Shimbori

Yuni Shimbori

  • School of Pharmacy
  • Nihon University, Japan

Speaker(s)

Tetsuo  Nakabayashi, MD, PhD

Tetsuo Nakabayashi, MD, PhD

  • Office of Medical Informatics and Epidemiology
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Motoki  Arakawa, PhD

Motoki Arakawa, PhD

  • Junior Associate Professor, School of Pharmacy
  • Nihon University , Japan
Katsuhiko  Ichimaru

Katsuhiko Ichimaru

  • Review Director, Office of New Drug IV
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Hideki  Maeda, PhD

Hideki Maeda, PhD

  • Professor, Department of Regulatory Science
  • Meiji Pharmaceutical University, Japan
Jun  Yamakami, PhD

Jun Yamakami, PhD

  • Senior Manager, R&D Regulatory 1, Regulatory Affairs
  • Sanofi K.K., Japan
Saki  Watanabe

Saki Watanabe

  • Monitoring Group
  • Pfizer R&D Japan G.K., Japan
Ryohei  Sato, MS

Ryohei Sato, MS

  • Department of Clinical Research and Development
  • Otsuka Pharmaceutical Co., Ltd., Japan
Minami  Mori

Minami Mori

  • Research&Development Solutions
  • IQVIA Services Japan K.K., Japan

Contact us